InvestorsHub Logo
Followers 61
Posts 7866
Boards Moderated 0
Alias Born 05/18/2007

Re: None

Wednesday, 10/19/2016 5:29:30 PM

Wednesday, October 19, 2016 5:29:30 PM

Post# of 2139
Patience is a virtue. After a few remarkable days a pull back for a day or two is inevitable.

The latest PR has the CEO telling us that the next set of results are expected by EOY 2016. So there is going to be consolidation between now and EOY - a bit of give and take, some moves by MMs to grab your shares by taking it down for no reason and people will panic and sell. You can probably reduce your average cost by selling and buying over and over again. Worth a try for those who can play the game. All said and done, this is highly undervalued even at this price and stage of the product cycle.

I have dabbled in man bio techs of the baby kind (in terms of market cap) and very very few have commanded the respect and shown promise as CTRV - would say it is one of a kind. We have a competent CEO who has the experience and wherewithal to see this through the homestretch and emerge a winner. Yes, he will need to raise some capital, but I would not be surprised if and when he does it from a point of strength - may be sometime early next year.

If the results are going to be outstanding then Big Pharma is not going to wait for long - they can afford to pay a huge premium given the low share count (float, O/S etc.)

I am in it to win it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HEPA News